Global study evaluates novel KRAS G12D-targeted protein degrader against docetaxel in previously treated advanced NSCLC, ...

Earendil Labs, an AI-powered biotechnology company advancing next-generation biologics, today announced a research ...

Verato ® announced a partnership with Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and ...

First-in-Class approval supported by Phase 3 BROADWAY, BROOKLYN, and TANDEM trials demonstrating significant LDL-C reductions ...

Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic ...

Strategic collaboration combines Sanyou Bio’s AI-powered antibody discovery and dual-target, dual-payload ADC capabilities ...

With embedded AI agents and clinical decision support built in, the context-aware EHR is expected to help care teams navigate ...

Turbine’s vLab platform will deploy computational Virtual Assays across Daiichi Sankyo’s proprietary ADC programmes to ...

New 9,940-square-metre Vision Centre in Southampton brings R&D, clinical expertise, AI-enabled technologies and pilot ...

The most consequential APAC biopharma deal of 2026 is Sun Pharma's all-cash agreement to buy Organon, which Sun describes as ...

Gibco CHO-K1 portfolio delivers up to 73% higher protein titres and 202% higher peak viable cell density, supporting faster ...

Figure 1. The 2026 approvals timeline: one dot per new active substance, by month and authority. Solid dots are ...